Molecular Tumor Board: Diagnostic Challenges in NSCLC

Catalog

VIKTOR

Podcast | English | 2026 | 54 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio Ricciuti, live from the Targeted Therapies of Lung Cancer (TTLC) 2026 conference. The discussion addresses the question, “How do we get the right molecular answer, at the right time, for the right patient?”

Podcast Host:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Misako Nagasaka, MD, PhD, Associate Clinical Professor, University of California, Irvine, CA, USA
Biagio Riccuiti, MD, PhD, Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Faculty, Harvard Medical School, Boston, MA, USA